|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 96.02 USD | -1.11% |
|
-2.09% | -2.78% |
| 11/03 | Incyte Corporation Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 09:20 AM | |
| 09/03 | Incyte Says FDA Declines Supplemental Biologics Application for Zynyz Injection | MT |
| Capitalization | 19.11B 16.41B 14.83B 14.2B 25.94B 1,755B 26.76B 175B 69.96B 841B 71.72B 70.2B 3,013B | P/E ratio 2026 * |
15.1x | P/E ratio 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise value | 13.6B 11.68B 10.56B 10.11B 18.47B 1,249B 19.05B 124B 49.8B 599B 51.06B 49.97B 2,145B | EV / Sales 2026 * |
2.43x | EV / Sales 2027 * | 1.92x |
| Free-Float |
97.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Incyte Corporation
| 1 day | -1.11% | ||
| 1 week | -2.09% | ||
| Current month | -5.18% | ||
| 1 month | -4.03% | ||
| 3 months | +0.89% | ||
| 6 months | +11.33% | ||
| Current year | -2.78% |
| 1 week | 94.52 |  | 99.35 |
| 1 month | 94.52 | | 103.9 |
| Current year | 94.52 | | 112.29 |
| 1 year | 53.56 | | 112.29 |
| 3 years | 50.27 | | 112.29 |
| 5 years | 50.27 | | 112.29 |
| 10 years | 50.27 | | 153.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 26/06/2025 |
Pablo Cagnoni
PSD | President | 62 | 05/06/2023 |
Thomas Tray
DFI | Director of Finance/CFO | 49 | 16/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 26/06/2025 |
| Director/Board Member | 72 | 20/01/2015 | |
Paul Clancy
BRD | Director/Board Member | 64 | 20/01/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.67% | 14.55% | 253 M€ | |
| 0.00% | 2.94% | 1 M€ | |
| -2.25% | 2.88% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.11% | -2.09% | +34.99% | +33.34% | 19.11B | |
| -1.22% | +0.70% | +3.65% | +3.35% | 79.23B | |
| -4.60% | -4.64% | +48.15% | +220.43% | 58.37B | |
| +0.82% | +59.20% | +59.20% | +59.20% | 50.28B | |
| -1.37% | -0.20% | -43.40% | -49.66% | 49.67B | |
| +0.09% | +2.39% | +25.01% | -26.56% | 27.65B | |
| -1.36% | +10.34% | +52.89% | -60.24% | 21.71B | |
| -1.75% | +8.63% | +111.81% | +115.05% | 19.03B | |
| -0.80% | -0.10% | +36.71% | +62.37% | 14.69B | |
| +13.22% | +15.17% | +136.69% | +428.59% | 14.41B | |
| Average | +0.35% | +4.40% | +46.57% | +78.59% | 35.41B | |
| Weighted average by Cap. | -0.75% | +3.26% | +31.25% | +60.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.6B 4.81B 4.35B 4.16B 7.6B 514B 7.84B 51.2B 20.5B 247B 21.02B 20.57B 883B | 6.19B 5.32B 4.81B 4.6B 8.4B 569B 8.67B 56.59B 22.66B 273B 23.23B 22.74B 976B |
| Net income | 1.31B 1.13B 1.02B 976M 1.78B 121B 1.84B 12.01B 4.81B 57.86B 4.93B 4.83B 207B | 1.54B 1.32B 1.19B 1.14B 2.08B 141B 2.15B 14.04B 5.62B 67.6B 5.76B 5.64B 242B |
| Net Debt | -5.51B -4.73B -4.27B -4.09B -7.47B -506B -7.71B -50.33B -20.16B -242B -20.66B -20.23B -868B | -7.2B -6.18B -5.59B -5.35B -9.77B -661B -10.08B -65.81B -26.35B -317B -27.02B -26.44B -1,135B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 96.02 $ | -1.11% | 1,547,972 |
| 09/03/26 | 97.10 $ | +1.21% | 1,521,176 |
| 06/03/26 | 95.94 $ | -1.43% | 1,255,015 |
| 05/03/26 | 97.33 $ | -1.55% | 1,331,361 |
| 04/03/26 | 98.86 $ | +0.81% | 1,628,585 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INCY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition